Skip to main content

Table 1 Patient demographics and social characteristics

From: Health outcomes and unmet needs in patients with long-standing rheumatoid arthritis attending tertiary care in Greece: a cohort study

Characteristics

Overall

Non-bDMARDs n = 87

bDMARDs n = 123

p-value

Sex, n (%)

N = 210

 Male

49 (23.3)

23 (26.4)

26 (21.1)

0.372

 Female

161 (76.7)

64 (73.6)

97 (78.9)

 

Age, (years)

N = 210

 Mean ± SD

59.1 ± 12.6

60.38 ± 13.05

57.32 ± 12.21

0.083

 IQR

51.8–67.8

55.0–68.0

49.0–67.0

 

Weight, (kg)

N = 187

 Mean ± SD

76.0 ± 14.8

NA

NA

 

 IQR

65.0–85.0

   

BMI, (k/m2)

N = 174

 Mean ± SD

28.1 ± 4.6

28.37 ± 4.39

27.92 ± 4.82

0.534

 IQR

24.9–30.5

25.5–31.2

24.7–30.3

 

Education, n (%)

N = 210

 No education

2 (1.0)

NA

NA

 

 Primary

113 (53.8)

   

 Secondary

63 (30.0)

   

 Higher

32 (15.2)

   

Smoker, n (%)

N = 210

 Never smoked

147 (70.0)

61 (70.1)

86 (69.9)

0.848

 Ex-smoker

32 (15.2)

15 (17.2)

17 (13.8)

 

 Time since stopped (years), Mean ± SD (n)

9.9 ± 10.5 (30)

   

 Packs/year, Mean ± SD (n)

30.1 ± 40.8 (25)

   

 Smoker

31 (15)

11 (12.6)

20 (16.3)

 

 Packs/year, Mean ± SD (n)

18.7 ± 14.1 (28)

   

Patient diagnosed for the first time

N = 210

 No, n (%)

208 (99.0)

85 (97.7)

123 (100)

0.092

  Time from first diagnosis (years), median (IQR)

11.9 (5.0–16.0)

10.0

11.0

 

 Yes, n (%)

2 (1.0)

2 (2.3)

0 (0)

0.469

  Duration of symptoms (months), median (IQR)

5.5 (4.0–7.0)

   
  1. bDMARD biologic disease-modifying antirheumatic drug, BMI body mass index, IQR interquartile range, SD standard deviation